LIRAGLUTIDE and VOMITING

Overview

VOMITING is the #3 most commonly reported adverse reaction for LIRAGLUTIDE, manufactured by Novo Nordisk. There are 3,364 FDA adverse event reports linking LIRAGLUTIDE to VOMITING. This represents approximately 4.2% of all 79,181 adverse event reports for this drug.

Patients taking LIRAGLUTIDE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING is moderately reported among LIRAGLUTIDE users, representing a notable but not dominant share of adverse events.

Other Side Effects of LIRAGLUTIDE

In addition to vomiting, the following adverse reactions have been reported for LIRAGLUTIDE:

• NAUSEA — 7,005 reports
• BLOOD GLUCOSE INCREASED — 3,875 reports
• DIARRHOEA — 3,264 reports
• PANCREATITIS — 2,318 reports
• WEIGHT DECREASED — 2,076 reports
• DECREASED APPETITE — 2,066 reports
• HEADACHE — 1,988 reports
• OFF LABEL USE — 1,728 reports
• FATIGUE — 1,635 reports
• DRUG INEFFECTIVE — 1,539 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

Does LIRAGLUTIDE cause VOMITING?

VOMITING has been reported as an adverse event in 3,364 FDA reports for LIRAGLUTIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with LIRAGLUTIDE?

VOMITING accounts for approximately 4.2% of all adverse event reports for LIRAGLUTIDE, making it one of the most commonly reported side effect.

What should I do if I experience VOMITING while taking LIRAGLUTIDE?

If you experience vomiting while taking LIRAGLUTIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages